Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

OLMA
Olema Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close
Sep 11, 2026 3:59:52 PM EDT
10.22USD-4.397%(-0.47)892,880
8.68Bid   12.48Ask   3.80Spread
Pre-market
Sep 10, 2026 9:11:30 AM EDT
10.32USD-3.461%(-0.37)0
After-hours
Sep 11, 2026 4:59:30 PM EDT
7.89USD-22.798%(-2.33)48,086
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
07:35AM EST  Olema Oncology Appoints Naseem Zojwalla As Chief Medical Officer   RTTNews
07:30AM EST  Dr. Zojwalla brings extensive and diverse experience in clinical development and regulatory strategy for novel oncology therapies   GlobeNewswire Inc
Jan 4, 2022
07:30AM EST  Olema Pharmaceuticals, Inc. (Olema or Olema Oncology, Nasdaq: OLMA), announced today that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview and update at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 5:15 p.m. ET (2:15 p.m. PT).   GlobeNewswire Inc
Nov 30, 2021
05:00PM EST  Mid-Afternoon Market Update: Dow Dips 500 Points; ImmunoGen Shares Spike Higher   Benzinga
04:56PM EST  Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Shares Jump   Benzinga
04:52PM EST  Mid-Morning Market Update: Markets Mostly Lower; JinkoSolar Issues Weak Sales Forecast   Benzinga
04:43PM EST  Stat News' Adam Feuerstein Tweets '$OLMA - I think the most logical, likely explanation: Y'day's leaked SABCS poster was real. Why/how it was leaked, still unexplained, but the data were real. Today's PR is an update w/ data cutoff one month later (Nov. 1) than SABCS poster (Oct.'   Benzinga
04:43PM EST  Olema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer   Benzinga
04:29PM EST  Olema Oncology Issues Statement Regarding Falsified Information Circulating On Social Media   Benzinga
04:29PM EST  UPDATE: Olema Oncology Says Poster Presentation Circulated On Social Media Was 'Falsified' And Not Released Or Authorized By Co.   Benzinga
07:07AM EST  Olema Oncology Announces First Clinical Data On OP-1250 In Advanced ER+ / HER2- Breast Cancer   RTTNews
07:00AM EST  Olema Oncology Announces First Clinical Data on OP-1250   GlobeNewswire Inc
Nov 29, 2021
04:27PM EST  Olema Oncology Issues Statement Regarding Falsified Information   GlobeNewswire Inc
Nov 22, 2021
07:35AM EST  Olema Oncology To Present New Data On OP-1250 At 2021 San Antonio Breast Cancer Symposium   Benzinga
07:30AM EST  -- Interim pharmacokinetic, safety and tolerability, and preliminary efficacy data from Phase 1 dose escalation to be presented -- Company to host investor webcast at 8:30 a.m. ET on Wednesday, December 8, 2021   GlobeNewswire Inc
Nov 10, 2021
05:39PM EST  Olema Pharmaceuticals Q3 EPS $(0.45) Up From $(3.71) YoY   Benzinga
Nov 9, 2021
07:30AM EST  Olema Pharmaceuticals, Inc. (Olema or Olema Oncology, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers, today announced that management will participate in two upcoming investor conferences in November.   GlobeNewswire Inc
Sep 30, 2021
05:00PM EDT  Olema Oncology Announces Trials in Progress Poster on OP-1250 at   GlobeNewswire Inc
Sep 9, 2021
07:31AM EDT  Olema Oncology To Present Data On OP-1250 At 2021 JCA-AACR Precision Cancer Medicine International Conference   Benzinga
07:30AM EDT  Olema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR   GlobeNewswire Inc
Aug 30, 2021
04:05PM EDT  Olema Oncology to Present at Morgan Stanley 19th Annual Global   GlobeNewswire Inc
Aug 10, 2021
04:53PM EDT  Olema Pharmaceuticals Q2 EPS $(0.42) Up From $(0.95) YoY   Benzinga
Jul 28, 2021
04:05PM EDT  Olema Oncology to Present at Canaccord Genuity 41st Annual Growth   GlobeNewswire Inc
May 18, 2021
04:05PM EDT  Olema Oncology to Participate at the Jefferies   GlobeNewswire Inc
May 11, 2021
04:37PM EDT  Olema Pharmaceuticals Q1 EPS $(0.39) Up From $(0.65) YoY   Benzinga
04:05PM EDT  -- OP-1250 continues to advance in dose-escalation stage of Phase 1/2 clinical trial in patients with metastatic, ER+ / HER2- breast cancer; Initial data anticipated in 2H 2021 -- Cash, cash equivalents, and marketable securities of $327.0 million as of March 31, 2021 sufficient to fund operations through the end of 2023   GlobeNewswire Inc
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
May 4, 2021
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
Apr 7, 2021
07:30AM EDT  Olema Oncology to Participate in the Canaccord Genuity Horizons in   GlobeNewswire Inc
Apr 6, 2021
07:30AM EDT  -- Ms. Larson Brings Significant Biotech Operational Leadership and Global Healthcare Banking Expertise to Olema as the Company Continues to Advance Its Pipeline -- Longstanding Olema Director Dr. Frank McCormick to Transition from Board of Directors and Return to His Position as Chairman of Olemas Scientific Advisory Board   GlobeNewswire Inc
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 26, 2021
07:28AM EDT  The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs   Benzinga
Mar 25, 2021
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
Mar 17, 2021
04:06PM EDT  Olema Pharmaceuticals Q4 EPS $(0.50) Down From $(0.39) YoY   Benzinga
04:05PM EDT  Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial   GlobeNewswire Inc
Mar 10, 2021
04:46PM EST  Olema Oncology Announces Late-Breaking Poster Presentation At The American Association for Cancer Research Annual Meeting 2021   Benzinga
04:45PM EST  Olema Oncology Announces Late-Breaking Poster Presentation at the   GlobeNewswire Inc
Feb 23, 2021
07:00AM EST  Olema Pharmaceuticals, Inc. (Olema or Olema Oncology, NASDAQ: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers, today announced that it will participate at the following upcoming virtual investor conferences:   GlobeNewswire Inc
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 17, 2020
08:10AM EST  The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut   Benzinga
07:00AM EST  Olema Oncology to Present at 39th AnnualJ.P. Morgan   GlobeNewswire Inc
Dec 16, 2020
07:15AM EST  The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal   Benzinga
Dec 14, 2020
12:18PM EST  Canaccord Genuity Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $60   Benzinga
Dec 13, 2020
04:27PM EST  The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics   Benzinga
Dec 7, 2020
07:39AM EST  Olema Oncology Announces Two Poster Presentations at the San   GlobeNewswire Inc
Nov 25, 2020
03:12PM EST  December Will Be The Big IPO Finale Of 2020   Benzinga
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 23, 2020
04:01PM EST  Olema Oncology Announces Closing of Initial Public Offering and   GlobeNewswire Inc
12:45PM EST  Last Week's IPO Recap   Benzinga
Nov 19, 2020
03:23PM EST  IPOs Happening Today, Thursday, Nov. 19, 2020: CHFW/U, JYAC, LNFA/U, NGMS, OLMA, RTPZ/U, TLS, YSG   Benzinga
11:10AM EST  Olema Pharmaceuticals Shares Open For Trade At $45; IPO Priced At $19/Share   Benzinga
09:42AM EST  Olema Pharmaceuticals Shares Will Open For Quote At 10:10 a.m. EST, Expected To Open For Trade After 10:20 a.m. EST, IPO Priced At $19.00/Share   Benzinga
Nov 18, 2020
08:10PM EST  Olema Oncology Announces Pricing of Initial Public Offering   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC